SYROS PHARMACEUTICALS, INC. Research and Development Expense
SYROS PHARMACEUTICALS, INC. reported Research and Development Expense of $20.53 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-09-30 was $20.53M, a 27.42% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-06-30 was $21.95M, a 25.85% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-03-31 was $24.66M, a 14.28% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. research and development expense for the quarter ending 2023-12-31 was $21.50M, a 22.97% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $108.15M, a 3.39% decline from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $111.94M, a 12.09% increase from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. research and development expense for fiscal 2021 was $99.87M, a 31.30% increase from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. research and development expense for fiscal 2020 was $76.06M, a 30.59% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $20.53M 10-Q · filed 2024-10-31 | $42.48M derived: sum of 2 quarters · filed 2024-10-31 | $67.13M 10-Q · filed 2024-10-31 | $88.64M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | $21.95M 10-Q · filed 2024-07-31 | $46.61M 10-Q · filed 2024-07-31 | $68.11M derived: sum of 3 quarters · filed 2024-07-31 | $96.39M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-03-31 | $24.66M 10-Q · filed 2024-05-14 | $46.16M derived: sum of 2 quarters · filed 2024-05-14 | $74.44M derived: sum of 3 quarters · filed 2024-10-31 | $104.05M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-12-31 | $21.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $49.78M derived: sum of 2 quarters · filed 2024-10-31 | $79.39M derived: sum of 3 quarters · filed 2024-10-31 | $108.15M 10-K · filed 2024-03-27 |
| 2023-09-30 | $28.28M 10-Q · filed 2024-10-31 | $57.89M derived: sum of 2 quarters · filed 2024-10-31 | $86.65M 10-Q · filed 2024-10-31 | $114.56M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $29.61M 10-Q · filed 2024-07-31 | $58.37M 10-Q · filed 2024-07-31 | $86.28M derived: sum of 3 quarters · filed 2024-07-31 | $112.04M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $28.76M 10-Q · filed 2024-05-14 | $56.67M derived: sum of 2 quarters · filed 2024-05-14 | $82.43M derived: sum of 3 quarters · filed 2024-05-14 | $115.53M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $27.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $53.67M derived: sum of 2 quarters · filed 2024-03-27 | $86.77M derived: sum of 3 quarters · filed 2024-03-27 | $111.94M 10-K · filed 2024-03-27 |
| 2022-09-30 | $25.76M 10-Q · filed 2023-11-14 | $58.86M derived: sum of 2 quarters · filed 2023-11-14 | $84.03M 10-Q · filed 2023-11-14 | $110.83M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $33.10M 10-Q · filed 2023-08-08 | $58.27M 10-Q · filed 2023-08-08 | $85.07M derived: sum of 3 quarters · filed 2023-08-08 | $112.33M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $25.17M 10-Q · filed 2023-05-10 | $51.97M derived: sum of 2 quarters · filed 2023-05-10 | $79.23M derived: sum of 3 quarters · filed 2023-05-10 | $105.01M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $26.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $54.06M derived: sum of 2 quarters · filed 2023-03-02 | $79.84M derived: sum of 3 quarters · filed 2023-03-02 | $99.87M 10-K · filed 2023-03-02 |
| 2021-09-30 | $27.26M 10-Q · filed 2022-11-14 | $53.05M derived: sum of 2 quarters · filed 2022-11-14 | $73.08M 10-Q · filed 2022-11-14 | $102.10M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $25.79M 10-Q · filed 2022-08-09 | $45.81M 10-Q · filed 2022-08-09 | $74.84M derived: sum of 3 quarters · filed 2022-08-09 | $92.52M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $20.03M 10-Q · filed 2022-05-16 | $49.05M derived: sum of 2 quarters · filed 2022-05-16 | $66.73M derived: sum of 3 quarters · filed 2022-05-16 | $81.53M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $29.03M 10-K · filed 2021-03-04 | $46.70M derived: sum of 2 quarters · filed 2021-11-05 | $61.50M derived: sum of 3 quarters · filed 2021-11-05 | $76.06M 10-K · filed 2023-03-02 |
| 2020-09-30 | $17.67M 10-Q · filed 2021-11-05 | $32.47M derived: sum of 2 quarters · filed 2021-11-05 | $47.04M 10-Q · filed 2021-11-05 | $61.32M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $14.80M 10-Q · filed 2021-08-05 | $29.36M 10-Q · filed 2021-08-05 | $43.64M derived: sum of 3 quarters · filed 2021-08-05 | $59.57M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $14.57M 10-Q · filed 2021-05-06 | $28.85M derived: sum of 2 quarters · filed 2021-05-06 | $44.78M derived: sum of 3 quarters · filed 2021-05-06 | $60.25M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $14.28M 10-K · filed 2021-03-04 | $30.21M derived: sum of 2 quarters · filed 2021-03-04 | $45.68M derived: sum of 3 quarters · filed 2021-03-04 | $58.24M 10-K · filed 2022-03-15 |
| 2019-09-30 | $15.93M 10-K · filed 2021-03-04 | $31.41M derived: sum of 2 quarters · filed 2021-03-04 | $43.97M 10-Q · filed 2020-11-05 | $59.10M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $15.47M 10-K · filed 2021-03-04 | $28.04M 10-Q · filed 2020-08-06 | $43.16M derived: sum of 3 quarters · filed 2021-03-04 | $56.02M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $12.56M 10-K · filed 2021-03-04 | $27.69M derived: sum of 2 quarters · filed 2021-03-04 | $40.55M derived: sum of 3 quarters · filed 2021-03-04 | $51.63M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $15.13M 10-K · filed 2020-03-05 | $27.98M derived: sum of 2 quarters · filed 2020-03-05 | $39.07M derived: sum of 3 quarters · filed 2020-03-05 | $50.18M 10-K · filed 2021-03-04 |
| 2018-09-30 | $12.86M 10-K · filed 2020-03-05 | $23.94M derived: sum of 2 quarters · filed 2020-03-05 | $35.05M 10-Q · filed 2019-11-12 | $46.83M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $11.08M 10-K · filed 2020-03-05 | $22.20M 10-Q · filed 2019-08-01 | $33.98M derived: sum of 3 quarters · filed 2020-03-05 | $44.42M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $11.12M 10-K · filed 2020-03-05 | $22.90M derived: sum of 2 quarters · filed 2020-03-05 | $33.34M derived: sum of 3 quarters · filed 2020-03-05 | $43.38M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $11.78M 10-K · filed 2019-03-07 | $22.23M derived: sum of 2 quarters · filed 2019-03-07 | $32.27M derived: sum of 3 quarters · filed 2019-03-07 | $41.90M 10-K · filed 2020-03-05 |
| 2017-09-30 | $10.45M 10-K · filed 2019-03-07 | $20.49M derived: sum of 2 quarters · filed 2019-03-07 | $30.12M 10-Q · filed 2018-11-01 | $38.56M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $10.04M 10-K · filed 2019-03-07 | $19.67M 10-Q · filed 2018-08-07 | $28.11M derived: sum of 3 quarters · filed 2019-03-07 | $39.70M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $9.63M 10-K · filed 2019-03-07 | $18.07M derived: sum of 2 quarters · filed 2019-03-07 | $29.66M derived: sum of 3 quarters · filed 2019-03-07 | $39.18M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $8.44M 10-K · filed 2018-03-12 | $20.03M derived: sum of 2 quarters · filed 2018-03-12 | $29.55M derived: sum of 3 quarters · filed 2018-03-12 | $37.82M 10-K · filed 2019-03-07 |
| 2016-09-30 | $11.58M 10-K · filed 2018-03-12 | $21.11M derived: sum of 2 quarters · filed 2018-03-12 | $29.37M 10-Q · filed 2017-11-08 | $37.75M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $9.53M 10-K · filed 2018-03-12 | $17.79M 10-Q · filed 2017-08-09 | $26.17M derived: sum of 3 quarters · filed 2018-03-12 | $33.03M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $8.27M 10-K · filed 2018-03-12 | $16.64M derived: sum of 2 quarters · filed 2018-03-12 | $23.51M derived: sum of 3 quarters · filed 2018-03-12 | $28.94M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $8.38M 10-K · filed 2017-03-20 | $15.24M derived: sum of 2 quarters · filed 2017-03-20 | $20.67M derived: sum of 3 quarters · filed 2017-03-20 | $24.41M 10-K · filed 2018-03-12 |
| 2015-09-30 | $6.87M 10-K · filed 2017-03-20 | $12.29M derived: sum of 2 quarters · filed 2017-03-20 | $16.03M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $5.43M 10-K · filed 2017-03-20 | $9.16M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $3.74M 10-K · filed 2017-03-20 | |||
| 2014-12-31 | $10.92M 10-K · filed 2017-03-20 |